Target intelligence / Profile preview

Coccidia-specific phosphate transporter (TgPT2) (TgPT2)

Target
TgPT2
Molecular classification
Transporter, Phosphate transporter, Nucleoside transporter
01

Overview

The **Coccidia-specific phosphate transporter (TgPT2)** is a membrane transporter found in *Toxoplasma gondii* and other coccidian parasites, localized to the plasma membrane and essential for parasite survival and growth[1]. TgPT2 mediates the uptake of inorganic phosphate (Pi) from the environment, which is critical for ATP production and overall parasite energy metabolism. Although ATP and AMP can competitively inhibit phosphate uptake, direct ATP import is not mediated by TgPT2, suggesting the existence of additional, as-yet-uncharacterized transport mechanisms[1][5]. TgPT2 is restricted to coccidia and not present in other apicomplexans, making it an attractive target for selective anti-coccidial drug design[1]. Disruption of TgPT2 leads to growth arrest, reduced motility, and impaired invasion, confirming its critical role in parasite pathogenicity[1]. While no direct drugs or biomarkers have been described against this transporter, its essentiality and specificity indicate strong potential as a novel therapeutic target in treating coccidiosis and toxoplasmosis. **Key clarification:** The term "Coccidia ATP transport" is not specific enough for structured biochemical taxonomy; for detailed molecular targeting, refer to the actual characterized transporters such as TgPT2. If you meant ATP synthase, mitochondrial carrier proteins, or general phosphate uptake machinery, these should be named explicitly for data standardization[1][4][5].

Other names
TgPT2Toxoplasma gondii phosphate transporter 2coccidia-specific phosphate transporter
02

Mechanism of action

Transport inhibition (disrupting phosphate or nucleotide uptake, potentially causing parasite energy deficit and death)

03

Biological functions

Nutrient uptakeSignal transductionCell proliferationHost-parasite interactionEnergy metabolism
04

Disease associations

Infection (toxoplasmosis, coccidiosis)Other (potentially general parasite viability)
05

Safety considerations

Potential off-target effects if host cells share similar transport mechanisms (although TgPT2 is stated to be coccidia-specific)Resistance development if only one transporter is targeted

Beyond the preview

Go deeper on Coccidia-specific phosphate transporter (TgPT2) (TgPT2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coccidia-specific phosphate transporter (TgPT2) (TgPT2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call